Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Galectin Therapeutics Inc.

NASDAQ: GALTHealthcare / Drugs - Generic / USA
5.26+0.15+2.94%Vol 197 9501Y Perf 117.85%
Dec 12th, 2018 16:00
BID5.25 ASK5.26
Open5.17 Previous Close5.11
Pre-Market- After-Trading-
 - -%  - -%
Target Price
12.00 
Analyst Rating
Strong Buy 1.00
Potencial %
128.14 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/-78/-85 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/-99/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/-99/-99 
Income Ranking
 —    -
Market Cap (mil)216 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
44.42 
Earnings Date
13th Nov 2018

Today's Price Range

5.085.30

 

52wk Range

1.889.49

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
5.36%
3 Months
-5.19%
6 Months
-19.27%
1 Year
117.85%
3 Years
190.34%
5 Years
-39.53%

Quotes

Name / TickerPriceChg.Chg.%
GALT5.260.15002.94
AAPL169.100.47000.28
GOOG1 063.6811.93001.13
MSFT109.080.49000.45
XOM76.02-0.6600-0.86
WFC47.74-0.0200-0.04
JNJ147.100.60000.41
FB144.502.42001.70
GE6.71-0.0500-0.74
JPM101.020.65000.65
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
6.20
Current Ratio
6.40
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-48.40
Leverage Ratio -2.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
11 358.30
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-16.90
Cash Flow Per Share
-0.31
Price to Tangible Book
11 358.30
Book Value per Share
0.00
Enterprise Value (in ths.)
203 266
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-284.75
ROE last 12 Months
461.75
Return on Assets (5Y Avg)
-226.58
ROA last 12 Months
-164.35
Return on Capital (5Y Avg)
-235.29
ROC last 12 Months
-707.25
Return on invested Capital Q
-707.25
Return on invested Capital Y
-218.11
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.09-0.0722.22
Q02 2018-0.12-0.118.33
Q01 2018-0.13-0.127.69
Q04 2017-0.11-0.0736.36
Q03 2017-0.14-0.137.14
Q02 2017-0.15-0.146.67
Q01 2017-0.15-0.150.00
Q04 2016-0.16-0.1318.75
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.120.00-
12/2018 QR-0.120.00-
12/2018 FY-0.440.00-
12/2019 FY-1.120.00-
Next Report Date-
Estimated EPS Next Report-0.09
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume197 950
Shares Outstanding (in ths.)41 140
Trades Count741
Dollar Volume888 542
Avg. Volume655 642
Avg. Weekly Volume192 172
Avg. Monthly Volume172 398
Avg. Quarterly Volume419 331

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

71%29%

Bearish Bullish

62%38%

Bearish Bullish

58%42%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News